Cytomegalovirus resistance in CD34+ -selected hematopoietic cell transplant recipients

Early recovery of T-cell function predicts improved survival after T-cell depleted allogeneic transplant

(2017) Jenna D. Goldberg et al.   LEUKEMIA & LYMPHOMA

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

(2017) Francisco M. Marty et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cytomegalovirus Infection after CD34 + -Selected Hematopoietic Cell Transplantation

(2016) Yao-Ting Huang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

How I treat resistant cytomegalovirus infection in hematopoietic cell transplantation recipients

(2016) F. El Chaer et al.   BLOOD

Definitions of Cytomegalovirus Infection and Disease in Transplant Patients for Use in Clinical Trials: Table 1.

(2016) Per Ljungman et al.   CLINICAL INFECTIOUS DISEASES

Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection

(2016) Robin K. Avery et al.   TRANSPLANTATION

Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality

(2015) J. Liu et al.   CLINICAL MICROBIOLOGY AND INFECTION

Approach to drug-resistant cytomegalovirus in transplant recipients

(2015) Sunwen Chou   CURRENT OPINION IN INFECTIOUS DISEASES

Cytomegalovirus-specific T-cell therapies: current status and future prospects

(2015) Emma Nicholson et al.   Immunotherapy

Monitoring of Cytomegalovirus Viral Loads by Two Molecular Assays in Whole-Blood and Plasma Samples from Hematopoietic Stem Cell Transplant Recipients

(2015) N. Esther Babady et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Improved Detection of Emerging Drug-Resistant Mutant Cytomegalovirus Subpopulations by Deep Sequencing

(2014) Sunwen Chou et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Clinical impact of neutropenia related with the preemptive therapy of CMV infection in solid organ transplant recipients

(2014) Cecilia Martín-Gandul et al.   JOURNAL OF INFECTION

Letermovir for Cytomegalovirus Prophylaxis in Hematopoietic-Cell Transplantation

(2014) Roy F. Chemaly et al.   NEW ENGLAND JOURNAL OF MEDICINE

The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations

(2014) S.-H. Choi et al.   Transplant Infectious Disease

Cytomegalovirus antiviral resistance: characterization of results from clinical specimens

(2014) S. Kleiboeker et al.   Transplant Infectious Disease

Geno- and Phenotypic Characterization of Human Cytomegalovirus Mutants SelectedIn Vitroafter Letermovir (AIC246) Exposure

(2013) Thomas Goldner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Ganciclovir-Resistant Cytomegalovirus Infections among Lung Transplant Recipients Are Associated with Poor Outcomes despite Treatment with Foscarnet-Containing Regimens

(2013) Lucio R. Minces et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

High Rate of Cytomegalovirus Drug Resistance Among Patients Receiving Preemptive Antiviral Treatment After Haploidentical Stem Cell Transplantation

(2013) Einat Shmueli et al.   JOURNAL OF INFECTIOUS DISEASES

The biology of cytomegalovirus drug resistance

(2011) Morgan Hakki et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Drug interactions and toxicities associated with the antiviral management of cytomegalovirus infection

(2010) T. Jacobsen et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Antiviral Drug Resistance of Human Cytomegalovirus

(2010) N. S. Lurain et al.   CLINICAL MICROBIOLOGY REVIEWS

How we treat cytomegalovirus in hematopoietic cell transplant recipients

(2009) M. Boeckh et al.   BLOOD